Get the Stockscreener App
16.01
0.93%
-0.15
After Hours:
16.01
Indivior Plc stock is traded at $16.01, with a volume of 1.54M.
It is down -0.93% in the last 24 hours and up +15.18% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$16.16
Open:
$16.19
24h Volume:
1.54M
Relative Volume:
1.08
Market Cap:
$1.93B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
1,601.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+3.49%
1M Performance:
+15.18%
6M Performance:
+37.42%
1Y Performance:
+53.06%
1-Day Range:
$15.97
$16.34
1-Week Range:
$15.00
$16.34
52-Week Range:
$7.33
$16.34
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
16.01 | 1.93B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
148.60 | 68.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 46.36B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.60 | 44.74B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.06 | 18.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.01 | 13.33B | 2.99B | 1.21B | 1.13B | 25.06 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
Indivior Plc Stock (INDV) Latest News
What drives Indivior PLC stock priceUnprecedented profits - Autocar Professional
What analysts say about Indivior PLC stockOverwhelming financial success - Jammu Links News
Is Indivior PLC a good long term investmentPhenomenal capital appreciation - Jammu Links News
Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st - Eastern Progress
Indivior PLC Stock Analysis and ForecastFree Real-Time Stock Data - Jammu Links News
Indivior PLC Executes Share Buyback Plan - TipRanks
Barclays Acquires Significant Stake in Indivior PLC - TipRanks
Indivior to Announce Q2 2025 Financial Results - TipRanks
Indivior to report Q2 2025 results on July 31 - Investing.com
Indivior to report Q2 2025 results on July 31 By Investing.com - Investing.com Nigeria
Indivior Sets Q2 2025 Earnings Release and Live Webcast: Key Details for Investors - Stock Titan
How To Trade (INDV) - news.stocktradersdaily.com
Indivior stock hits 52-week high at 15.9 USD By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 15.9 USD - Investing.com Australia
Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire
Hawaii to receive up to $2.4M in latest opioid settlement - Spectrum News
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs - PR Newswire
Indivior Strengthens Leadership: Former Sage Therapeutics SVP Joins to Advance Opioid Crisis Solutions - Stock Titan
Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? - MSN
Indivior stock hits 52-week high at $15.52 - Investing.com Australia
Indivior stock hits 52-week high at $15.52 By Investing.com - Investing.com Canada
Indivior PLC (INDV) Stock Price Up 4.02% on Jul 2 - GuruFocus
Indivior PLC Announces Change in Major Holdings by Barclays - The Globe and Mail
Indivior to join Russell 2000 Index - MSN
BlackRock Increases Stake in Indivior PLC - TipRanks
Indivior PLC Announces Changes in Major Shareholder Voting Rights - TipRanks
Indivior PLC Updates Share Capital and Voting Rights - TipRanks
Indivior price target raised to $22 from $16 at Northland - TipRanks
Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes - GuruFocus
Indivior Joins U.S. Russell Indexes, Boosting Market Presence - TipRanks
Indivior appoints Tony Kingsley to board of directors - Investing.com
Two Seas Capital LP Increases Stake in Indivior PLC - GuruFocus
Indivior Appoints Tony Kingsley to the Board of Directors – Company Announcement - Financial Times
Indivior adds biopharmaceutical executive Kingsley to board By Investing.com - Investing.com UK
Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users - Longview News-Journal
Indivior PLC Announces Changes in Major Holdings - TipRanks
Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com
Indivior PLC Corrects Director Shareholding Disclosure - TipRanks
REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView
Naloxone Market to Reflect Significant Incremental - openPR.com
Indivior Directors Increase Stake in Company Shares - TipRanks
Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com
Substance Abuse Treatment Market Size, Trends & Growth - openPR.com
Indivior PLC Announces Changes in Major Shareholdings - MSN
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter
INDV DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline - ACCESS Newswire
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):